Find an expert

Dr Stina Oftedal is an accredited practicing dietitian and postdoctoral research fellow at the Queensland Cerebral Palsy Rehabilitation Research Centre (QCPRRC). Stina completed her undergraduate degree at Queensland University of Technology in 2010, and completed her PhD at the University of Queensland in 2016. Stina's PhD explored the association of modifiable health behaviours (diet and physical activity) on growth and body composition in preschool-aged children with cerebral palsy, and this continues to be the focus of her postdoctoral work. She also has an interest in infant feeding and diet quality.

Dr Gerry Olive is a Queensland trained Respiratory Physician and early career researcher, undertaking a PhD in the field of lung cancer diagnosis. He has a keen clinical and research interest in the diagnostic approach to nodules and diagnostic bronchoscopy, including endobronchial ultrasound.

Rebecca Olson is an Associate Professor of Sociology at the University of Queensland, cutting-edge translational qualitative researcher, mentor and award-winning educator with expertise in the sociologies of health and emotions. As Director of SocioHealthLab, she leads an interdisciplinary collective of researchers, health professional educators and practitioners interested in doing health and healthcare differently: more socially aware, more relational, more inclusive and more just. As Director of Teaching and Learning in the School of Social Science, she prioritises collaborative, reflexive, creative and emotions-centred practices in higher education. With over 75 scholarly publications – as well as news media and creative video productions – Rebecca is a prolific contributor to public debate. With research interests spanning medicinal cannabis and health professions education to climate anxiety, Olson is internationally renowned for bringing sociological insight to complex challenges related to emotions, wellbeing, healthcare and caregiving.

Dr Natacha Omer is a paediatic oncologist at the Queensland Children's Hospital in Brisbane. She is specialised in solid tumours, with a spacial interest in paediatric and adolescent sarcomas, cancer immunotherapy and molecular oncology. She is undertaking a PhD in immunology studying natural killer (NK) cell immunotherapy in paediatric sarcomas at the Frazer Institute, University of Queensland, in Dr Fernando Guimaraes lab.

Desmond Ong is currently a Clinical Academic in the Discipline of Orthodontics at the University of Queensland School of Dentistry, where he is involved in both the Undergraduate and Postgraduate Orthodontic Programs.

Desmond is also in full-time specialist orthodontic private practice in Townsville.

Desmond received the Raj Prasad Award from the Australian Society of Orthodontists (SA) in 2016 and is a past winner of the Young Lecturer Award from the Royal Australasian College of Dental Surgeons.

Dr Osborne, BSc(Hons), MAgSc, PhD is an epidemiologist and toxicologist with research interests in using environmental epidemiology to examine aetiology and pathological pathways of disease. He has worked on a range of projects examining environmental exposures and health outcomes including exposure to metals, pollen, mould, chronic exposures to low levels of chemicals, pesticide and cyanotoxins. He also has experience examining how exposure to the environment may increase health and wellbeing (green/bluespace and solar irradiance and vitamin D).

He has developed skills in the linkage of environmental and population health data in an interdisciplinary context, and has expertise in design, linkage, hypothesis formulation, analysis, interpretation, translation and dissemination.

He has experience in designing and collecting epidemiological data and initiating studies of primary collected data (HealthIron, HealthNuts, Cornwall Housing Study, Survey of Recreational Water Users, Monitoring of Meniere’s Symptoms).

He also has used secondary data from existing cohorts (NHANES, UK Biobank, 1958 Birth Cohort, British Household Survey, Melbourne Collaborative Cohort Study, South Asian Clinical Toxicology Research Collaboration), as well as linkage of previously unconnected “big data” sets in mashups on novel platforms (MEDMI project). He has used traditional statistical methods such as linear/logistic regression, time series analysis, interrupted time series and Cox regression to ascertain associations between exposures and outcomes, as well as integrating confirmatory structured equation modelling with environmental/health data sets to construct conceptual diagrams of associations and assess pathway directions.

He currently researches pollen and health outcomes as well as chronic kidney disease in low to middle income countries.

He has supervised 6 PhD students to completion (2 primary supervisor, 4 co-supervisor) and currently supervises 4 PhD student. He has been associate editor of Archives of Environmental and Occupational Health since 2011 and is on the editorial board of International Journal of Epidemiology and Pediatric Allergy, Immunology and Pulmonology. He is a member of Australasian Epidemiology Association, International Society of Environmental Epidemiology and International Epidemiology Association.

He has previously worked at the Universities of NSW, Sydney, Exeter, Melbourne, Portsmouth, Queensland and Flinders, the Murdoch Children’s Research Institute and the Cancer Council Victoria. He completed his PhD at the School of Population Health, University of Queensland/National Research Centre of Environmental Toxicology working on the toxicology and public health effects of cyanobacterial toxins in southeast Queensland.

Dr Nancy A. Pachana is a clinical geropsychologist, neuropsychologist and Professor of Clinical Geropsychology in the School of Psychology at The University of Queensland. She is Program Lead of the Age Friendly University Initiative at UQ. She is also co-director of the UQ Ageing Mind Initiative, providing a focal point for clinical, translational ageing-related research at UQ. She has an international reputation in the area of geriatric mental health, particularly with her research on late-life anxiety disorders. She is co-developer of the Geriatric Anxiety Inventory, a published brief self-report inventory in wide clinical and research use globally, translated into over two dozen languages. She has published over 350 peer-reviewed articles, book chapters and books on various topics in the field of ageing, and has been awarded more than $25 million in competitive research funding, primarily in the areas of dementia and mental health in later life. Her research is well-cited cited and she maintains a clear international focus in her collaborations and research interests, which include anxiety in later life, psychological interventions for those with Parkinson’s Disease, nursing home interventions, use of assistance animals in later life, older adults and environmental sustainability, strategies for healthy ageing and healthy retirement, driving safety and dementia, teaching and learning in psychogeriatrics and mental health policy and ageing.

Her edited book, Casebook of Clinical Geropsychology (Oxford University Press, 2010), has proven a popular text for clinical geropsychology training in North America. Her edited book, the Oxford Handbook of Clinical Geropsychology (Oxford University Press, 2014), brings together an international perspective on a wide range of current and emerging topics in the field. Her Encyclopedia of Geropsychology (Springer, 2016) contains nearly 350 entries by international experts. Her text Ageing, A Very Short Introduction (2016), part of the popular Oxford University Press VERY SHORT INTRODUCTION series; this work has recently been translated into Chinese and Vietnamese. Most recently, she has edited Anxiety in older people: Clinical and research perspectives (Cambridge University Press, 2021) with longstanding colleague Professor Gerard Byrne (UQ Psychiatry).

Nancy was elected a Fellow of the Academy of Social Sciences in Australia in 2014. She is also a Fellow of the Australian Psychological Society, and is the recipient of numerous prizes and awards, including an Australian Davos Connection Future Summit Leadership Award, for leadership on ageing issues in Australia. In 2020 she was named the recipient of the M. Powell Lawton Lifetime Acievement Award, from the American Psychological Association’s Society of Clinical Geropsychology, acknowledging considerable and sustained efforts, in scholarship, publishing, and service, to promote geropsychology in general and the well-being of persons living with dementia in particular.

She serves on the editorial boards of several journals, including Psychology and Aging (Q1). Originally from the United States, Nancy was awarded her AB from Princeton University in 1987, her PhD from Case Western Reserve University in 1992, and completed postdoctoral fellowships at the Neuropsychiatric Institute at UCLA, Los Angeles, and the Palo Alto Veterans Medical Center, Palo Alto, California. She is an avid bird watcher and photographer and an intrepid traveller.

Dr Antonio Padilha L. Bo completed the BEng and MSc at the University of Brasília, Brazil, in 2004 and 2007, respectively, and he was awarded the PhD from the University of Montpellier, France, in 2011. From 2011 to 2019, he has been a tenured assistant professor in electrical engineering at the University of Brasilia, Brazil, where he coordinated Project EMA (Empowering Mobility and Autonomy), which is one of the teams that took part in the Cybathlon competition in 2016 and 2020. He has co-authored over 75 peer-reviewed publications, including awards from societies such as IFAC, IFESS, and MICCAI.

Over the past ten years, Dr Bo has been engaged in research projects concerning the development of technology dedicated to healthcare, particularly in the design of systems to be directly used by a patient in rehabilitation or assistive settings. Every effort featured strong experimental work and was conducted in close collaboration with local rehabilitation centers. In his work, tools from neuroengineering, robotics, control, virtual reality, and instrumentation are often integrated to create devices and algorithms to sense and control human motion. For instance, he has used wearable sensors to segment and estimate parameters of human movement in real-time, a technique that may lead to novel rehabilitation protocols. More importantly, his work has also focused on developing closed-loop control strategies for electrical stimulation applications and prosthetic/orthotic devices. Some examples include systems based on superficial electrical stimulation to enable persons with spinal cord injury to exercise using the lower limbs (e.g. in cycling or rowing) and to attenuate the effects of pathological tremor in essential tremor and Parkinson's Disease.

His long-term research goal is to develop and evaluate the use of noninvasive technology, including electrical stimulation, robotics, virtual reality, and wearable devices, for improving rehabilitation and assistance for persons with motor disabilities.

Chiara is Professor in Veterinary Pathology at the School of Veterinary Science (SVS) of the University of Queensland (UQ). She is a board certified specialist veterinary pathologist (Diplomate of the European College of Veterinary Pathology), graduated with a DVM from the University of Teramo (Italy) in 2002 and a PhD in Ultrastructural Pathology in 2006. Before joining UQ in 2012, she has been working as an Assistant Professor in Veterinary Pathology at the University of Teramo (Italy). She has a specific research interest is small animal oncology, in particular canine prostate cancer, and veterinary oncoepidemiology. She is Chair of the canine prostate cancer subgroup at the Oncology Pathology Working Group (OPWG), co-coordinator of the Global Initiative for Veterinary Cancer Surveillance (GIVCS) committee for the establishment of international standards of veterinary cancer registration and team leader of the comparative oncology theme of the Queensland Alliance of One Health Science. She is also member of the board of the Veterinary Cancer Guidelines and Protocols (VCGP) group, member of the Oncology Committee of the World Small Animal Veterinary Association (WSAVA) and chair of the ESVP/ECVP DEI task force. She is past President of the Australian Society for Veterinary Pathology and, within UQ SVS, she has been postgraduate coursework coordinator (2014-2017), HDR coordinator (2017-2019) and Director of Research (2019-2021). She is now coordinator of the UQ SVS veterinary pathology postgraduate training program. She has received several academic awards, including SVS awards for research excellence (2017, 2021), best lecturer (2021, 2022, 2023, 2024), and UQ award for excellence in HDR supervision (2020). She has published more than 120 papers on international journals, 3 book chapters and numerous abstracts in proceedings of national and international conferences. She has > 15 years expertise in veterinary diagnostic pathology, histopathology, IHC and TEM in multiple species. Since her first academic appointment in 2005, she mentored several postgraduate and undergraduate students in diagnostic investigation of animal cancer and research in canine oncology. Although outside the field of comparative oncology, she also a unique expertise in avian pathology and transmission electron microscopy.

Career Summary: 2009: PhD, University of Michigan, USA with training in cardiac physiology, modelling myocardial ischemia in vivo and in vitro, and development of therapeutic approaches for myocardial ischemia; 2009–2015: Postdoctoral Research Fellow, University of Washington, Institute for Stem Cell and Regenerative Medicine, USA with training in stem cell biology, genomics, genome editing, and cell therapeutics for ischemic heart disease; 2015–current: Group Leader, University of Queensland (UQ), Institute for Molecular Bioscience; 2022-current: Associate Professor, UQ; 2018–2021 and 2023-2026: National Heart Foundation Future Leader Fellow. Dr. Palpant’s research team has expertise in human stem cell biology, computational genomics, and cardiac physiology, which enables them to translate outcomes from cell biology and genomics to disease modelling, drug discovery, and preclinical modelling.

Prof Ben Panizza is the Chairman of Otolaryngology - Head and Neck Surgery for Metro South and Director of the Queensland Head and Neck Cancer Centre. He has been active in head and neck cancer management for 27 years. He has created innovative approaches in dealing with malignancies extending to the skull base one of the most anatomically complex regions of the body. He is recognised as a world leader in cutaneous malignancy extending to the temporal bone and perineurial spread of keratinocyte skin cancers, being regularly invited overseas to present. Prof Panizza is active in integrating new treatments with surgery to change treatment paradigms and improve outcomes for patients. He is a professor in the Faculty of Medicine at the University of Queensland and works collaboratively with basic scientist and has supervised to completion 28 research higher degrees over the last 12 years. He has established an in department clinical trials unit to run clinical trials from proof of principle to phase 3 clinical trials enabling access and rapid translation for his scientific partners at the Princess Alexandra Hospital which has one of Australia's largest head and neck clinics. Prof Panizza is a clinical consultant and advisor to industry (Merck, Sanofi, QBiotics, Decibel Therapeutics) and sits on the governing bodies of both the International Federation of Head and Neck Oncological Societies and The World Federation of Skull Base Societies. He has been the President of the Australian and New Zealand Head and Neck Cancer Society and was the Foundation president of the Australian and New Zealand Skull Base Society. He is active in publishing and sits on the editorial boards of the major head and neck journals (Head Neck, Oral Oncology, Skull Base, ANZ Journal of Surgery).

Zoe is a Honorary Research Fellow with the School of Human Movement and Nutrition Sciences. She also currently holds an appointment as a Senior Research Officer with the Mental Health Evaluation Research Stream at Queensland Centre for Mental Health Research (QCMHR), where she leads and manages large-scale evaluation projects that seek to enhance mental health services within Queensland. During her time at QCMHR, she has worked on several state-wide evaluations for Queensland Health - including of their Crisis Support Spaces, Adolescent Day Program and Youth and Adult Step-Up-Step-Down Programs.

Zoe's research work largely focuses on the development, implementation and evaluation of interventions that seek to promote positive health behaviours and which improve social and mental health outcomes. Previously, she developed and trialled a behavioural support program (Active Choices) for the Department of Veterans Affairs, with the aim of increasing self-managed physical activity and social connectedness in Australian Defence Force veterans. Zoe has also designed and evaluated a brief motivational intervention for cannabis users (iAx), which is now in routine use at the Princess Alexandra Hospital.

In addition to her work as a researcher, Zoe has held roles in health consulting where she assisted State and Federal Government agencies, PHNs and peak bodies to design, implement and review health services, programs and policies.

Zoe's educational background in psychology, having completed a Bachelor of Psychological Science (2013) and Doctor of Philosophy (2020) in this discipline.

Marie-Odile Parat (MO) joined the School of Pharmacy as Senior Lecturer in December 2007.

MO obtained her Pharm.D. from University Joseph Fourier in Grenoble, France, a Masters in Cutaneous Biology from University Claude Bernard in Lyon, France and her Ph.D. in Cell Biology from University Joseph Fourier in Grenoble, France. She further has post graduate diplomas in the fields of Biomedical and Industrial Pharmacy, Photobiology, Pharmaceutical Management, and Public Health.

MO did her Pharmaceutical Residency at the University Hospitals of Grenoble, France in the Sterile Pharmaceutical Supplies Headquarters, the Department of Nuclear Medicine, and the Laboratory Medicine Department of Biochemistry. Attracted by international working experience, she carried out research within the R&D laboratories of Estee Lauder in Melville, NY. She further worked for the United Nations International Trade center in Geneva, Switzerland, where she was the Product Specialist on market information for pharmaceutical raw materials/essential drugs for three years in collaboration with the World Health Organization.

She later performed post-doctoral research in the Universidade de São Paulo, SP, Brasil and The Cleveland Clinic Foundation in the United States. She was appointed as a Staff Scientist in the Center for Anesthesiology Research of the Cleveland Clinic in 2003, an Assistant Professor of Molecular Medicine in the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, and a Member of the Case Cancer Center.

During her research career MO has attracted awards from various funding agencies including the Research Funding Agency of the State of São Paulo (FAPESP), the American Heart Association, the Ohio Cancer Research Associates, the American Cancer Society, the National Heart Foundation of Australia, Cancer Council Queensland, Australian and New Zealand College of Anaesthetists and the Australia Research Council (ARC).

The long term goal of the Parat laboratory is to provide insight for novel cancer therapies. A basic science team focusses on endothelial and cancer cell migration, invasion, angiogenesis, and specialized plasma membrane subdomains termed caveolae. A translational axis of research evaluates novel mechanisms by which opioids administered to cancer patients modulate the risk of long term tumour recurrence and metastasis.

Harendra's research interests are in the area of synthetic pharmaceutical chemistry, pharmaceutics as applied to nano-carriers, and advanced non-viral drug/gene delivery system design, synthesis and evaluation. His team at PACE have been instrumental in developing highly versatile micro- & nanobubble formulations, which when used in-conjuction with ultrasound, pave the way for improved rates of 'on-demand' drug delivery and release in target tissue. Harendra also has a keen interest in developing bioresponsive drug/gene delivery systems with current engagement with pharma partners, globally, to commercialise his platforms. Separately, Dr Parekh has been developing a program to reformulate TCMs, in collaboration with researchers at a leading Chinese research institute; the outcomes of this work was aired across Asia in a BBC World News story, and showcased (TV & radio) by the Australian Academy of Science, National Touring Series.

BScPharm(Hon I), PhD (Nottingham)

Harendra completed his BSc in pharmacy (UK) and registered as a Pharmacist in 1998. He went onto undertake his PhD in Medicinal Chemistry at the University of Nottingham in the same year. Under the supervision of Dr B. Kellam and Dr. S. R. Chhabra he investigated the development of novel linkers for solid phase peptide and glycopeptide synthesis. Harendra was awarded his PhD in 2002, and after a short time working in community pharmacy in the UK relocated to Australia and took up a position as research officer in the School of Chemistry at UQ. He continues to be a member of the Royal Pharmaceutical Society of GB and is also registered with the AHPRA (pharmacist) in QLD.

During his post-doctoral tenure he explored the area of non-viral gene delivery via chemical synthesis of novel dendrimeric systems. Emphasis was on the treatment of age-related macular degeneration and in 2004 he received Uniquest's Trailblazer Prize for commercialisation potential. In May 2005 Dr Parekh was appointed Lecturer within the School of Pharmacy, and promoted to Senior Lecturer in 2011. He also holds adjunct positions at Manipal University (India), and the National University of Singapore's Nanoscience and Nanotechnology Institute (NNI).

I am an Associate Professor and Organisational Psychologist at UQ's School of Psychology. I research, supervise, teach, and consult on a broad range of work and organisational topics. Through my research, I aim to help organisations and their employees devise new strategies for balancing and realising the dual concerns of feeling well and performing well. To this end, I have researched employee stress, well-being, motivation, and performance in a range of high-performance settings (e.g., small business owners, professional musicians, elite athletes, and safety critical work in healthcare and transport industries). I also supplement this field research with a program of basic research in my laboratory using work simulation paradigms.

Some of my specific research topics include: how workers manage their energy during work; how workers recover from work stress in off-the-job time; how jobs and careers can be designed to maximise well-being, motivation, and performance; and I also explore the 'hidden costs' of performance management systems. Beyond these core areas, I have also contributed to other topics through theoretical (i.e., self-determination theory) and methodological (i.e., physiology, experience sampling, work simulation) expertise in academic, industry, and student-based collaborations. For example, in areas like supervisor support, diversity and inclusion, employee voice, employee green behaviour, compassion science, and social identity.

Passionate about doing practically-relevant research, though my consulting and advisory work I have helped both public and private organisations tackle issues with selection and recruitment, training and development, career management, work design, culture change, and operational safety. I also regularly engage with the media on topics related to my expertise and my research and/or commentary has been featured in outlets like TIME Magazine, Harvard Business Review, HR Magazine, and ABC’s popular podcast This Working Life.

I currently serve on the Editorial Boards for the Journal of Occupational Health Psychology and the European Journal of Work and Organisational Psychology.

Dr Brad Partridge has been a researcher in hospitals and universities for almost 20 years. His work has covered ethical, social, and policy issues related to a range of topics in healthcare including addiction, concussion management, psychiatry, midwifery, and biomedical enhancement technologies. He has written about conflicts of interest, medicalisation, and stakeholder attitudes towards models of treatment, and has extensive experience using qualitative research methods.

Brad joined the UQ Business School in April 2023 where he is exploring trust, and the attitudes of clinicians, towards incorporating Artificial Intelligence (AI) tools into the clinical decision-making process for melanoma detection, as part of an NHMRC Synergy Grant.

Brad was previously a postdoctoral research fellow in biomedical ethics at Mayo Clinic (Minnesota, USA), and was a visiting research fellow with the Neuroethics Research Group at the Montreal Clinical Research Institute (IRCM), in Canada. From 2011-2014 he was an NHMRC postdoctoral fellow with the addiction neuroethics group led by Prof. Wayne Hall at the University of Queensland Centre for Clinical Research (UQCCR). There, he was a Chief Investigator on two ARC Discovery Grants related to 1) the non-medical use of prescription stimulants, and 2) the ethical, social and policy implications of neurobiological explanations of addiction. Between 2015-2023 he held research in public hospitals within Metro-North Hospital and Health Service (Queensland Health), and at the Queensland Centre for Mental Health Research (QCMHR).

Brad’s PhD was from the University of Queensland School of Public Health. He also has a Master of Arts in Philosophy, and Bachelor of Psychology (Hons) from the University of New England.

Nalini has more than 25 years’ experience in innovative design and delivery of medicine and health programs in several countries. Her medical education research focusses on curriculum and assessment design, digital and inclusive education, and integration of biomedical sciences into health professional programs. She has a particular interest in educational technologies (including AI) and cognitive load, and curricular approaches that support positive learning behaviour, wellbeing, critical thinking and professional development. Nalini's research also includes medical imaging diagnositics and the use of AI.

Nalini is the co-founder of the Health Universities Initiative, which frames a whole-of-university approach to student success and wellbeing. She has several awards (Faculty, Vice-Chancellor, Australian Award for University Teaching) for her contributions to higher education. Nalini is the Chair of the International Program for Anatomical Education (FIPAE) of the IFAA, and an Associate Editor of Anatomical Sciences Education (Impact Factor, 7.2). Nalini is a Board Member and Fellow of ANZAHPE, Fellow of the Scientia Education Academy, and Fellow of HERDSA.

Nalini currently supervises 5 PhD students in the following topics:

• Health Advocacy in Medical Education: Evaluation of current practice and implications for medical programs
• Cosmetic female surgery: A consumer-driven evaluation of demand and its implications for medical education
• Fetal and Embryological Collections: A paradigm to examine the ethical practice of informed consent
• Anatomical Education: The role of digital-based pedagogies in future practice
• Liver and Gallbladder Imaging in Paediatric Patients: Developing a pipeline for diagnostic automation

Nalini currently supervises 4 reseach honours students on the following topics:

• Relationship-based support interventions in medical programs
• An evaluation of intersex education in medicine programs in Australia
• Left ventricular compaction: evaluation of MRI diagnostic criteria
• VR in biomedical sciences education: current scope of practice

Dr Cassandra Pattinson research centres around exploring the effects of sleep and circadian rhythms on health, wellbeing, and recovery across the lifespan. Dr Pattinson is a Senior Research Fellow at the Child Health Research Centre (CHRC) and the ARC centre of Excellence for the Digital Child. The Digital Child aims to support children growing up in the rapidly changing digital world, and provide strong evidence and guidance for children, families, educators, government and other concerned with children’s wellbeing. Her work has been supported by the ARC (including recently awarded an ARC Discovery Early Career Award, 2025), NHMRC, NIH and the DSTG, as well as the Australian Federal Government and Queensland Government.

Her research has involved a range of populations from children and adolescents, through to military personnel and athletes. Dr Pattinson's research spans a range of study designs and methodologies, including longitudinal studies tracking large child cohorts (>2000 children), standard observation techniques, survey and individualised standard child assessment, as well as studies employing physiological (actigraphy, spectrometry) and biological (hormones, proteomic, genomic) designs. Dr Pattinson also has a strong track record in research translation, these have included manuscripts in top scientific journals, reports for government and non-government organisations, development of professional development programs, as well as designing and presenting vodcasts and resources (e.g. fact sheets, workshops) to parent groups, young adults, government departments and the early childhood sector.

At CHRC Dr Pattinson is a part of the Community Sleep Health Group. This group collaborates with many other groups around broader issues of sleep and technology, sleep and the environment (including disasters), mental health and wellbeing, pain, disability, and new technologies and approaches.